Regarding the specific affinity of α-MSH peptide analogs for MC-1, radiolabeling of this agent with beta emitters has been suggested as a promising treatment modality for chemotherapy resistant melanomas (14, 15). This evidence concerns the gene ATP7A and melanoma.